November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The anti-aging market size is expected to rise from USD 84.4 billion in 2026 to USD 129.88 billion by 2034, gr...
Read MoreNovember 26, 2025
The U.S. behavioral health market is anticipated to grow from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreOctober 07, 2025
According to market projections, the specialty medical chairs sector is expected to grow from USD 4.77 billion in 2024 to USD 9.77 billion by 2034, reflecting a CAGR of 7.43%. In 2024, North America led the specialty medical chairs market with a 43% share, while Asia-Pacific is set for strong growth. Rehabilitation chairs dominated, but treatment c...
October 06, 2025
According to market projections, the E-pharmacy sector is expected to grow from USD 96.94 billion in 2024 to USD 435.82 billion by 2034, reflecting a CAGR of 16.44%. The E-pharmacy market is growing due to rising government support for e-healthcare services. North America is dominant in the market due to its advanced healthcare infrastructure and h...
October 06, 2025
According to market projections, the global sleep disorder market, valued at USD 27.67 billion in 2024, is anticipated to reach USD 70.54 billion by 2034, growing at a CAGR of 10.03% over the next decade. The sleep disorder market is growing significantly due to rising occupational mental health issues and demand for treatment among employees. Nort...
October 06, 2025
Based on market forecasts, the APAC behavioral health sector will expand from USD 19.07 billion in 2024 to USD 56.58 billion by 2034, experiencing a CAGR of 11.49%. The rising prevalence of mental health disorders and technological advancements drive the market....
October 01, 2025
The market is growing due to the increasing outsourcing of manufacturing and development services to improve efficiency and reduce costs. North America dominates the market, driven by a strong presence of medical companies and advanced healthcare infrastructure....
October 01, 2025
Market insights predict the global biopharmaceutical CDMO industry will increase from USD 20.55 billion in 2024 to USD 46.98 billion by 2034, achieving a CAGR of 8.73%. The biopharmaceutical CDMO market is expanding due to growth in research and development. North America led the market due to the presence of large biopharmaceutical ecosystems....